Pharmacogenomics and personalized medicine: lost in translation?

Por Hulot, Jean-Sébastien
Publicado em 2010

COVID-19 in patients with cardiovascular diseases

Por Hulot, Jean-Sébastien
Publicado no Arch Cardiovasc Dis (2020)

Modeling Cardiovascular Disease in Human Pluripotent Cells by Genome Editing

Por Hajjar, Roger J., Hulot, Jean-Sebastien
Publicado no J Am Coll Cardiol (2014)

Myocardial Delivery of SDF1 in Patients with Ischemic Heart Disease: Safe & Promising

Por Hajjar, Roger J., Hulot, Jean-Sebastien
Publicado no Circ Res (2013)

Gene therapy for the treatment of heart failure: promise postponed

Por Hulot, Jean-Sebastien, Ishikawa, Kiyotake, Hajjar, Roger J.
Publicado no Eur Heart J (2016)

Antiplatelet drug interactions with proton pump inhibitors

Por Scott, Stuart A, Obeng, Aniwaa Owusu, Hulot, Jean-Sébastien
Publicado em 2013

Assessment of signal quality measured with a smart 12‐lead ECG acquisition T‐shirt

Por Fouassier, David, Roy, Xavier, Blanchard, Anne, Hulot, Jean‐Sébastien
Publicado no Ann Noninvasive Electrocardiol (2019)

The Pharmacogenetic Control of Antiplatelet Response: Candidate Genes and CYP2C19

Por Yang, Yao, Lewis, Joshua P., Hulot, Jean-Sébastien, Scott, Stuart A.
Publicado no Expert Opin Drug Metab Toxicol (2015)

2525 Development of human cell-based screening assays to detect subject-specific drug-response variability

Por Stillitano, Francesca, Mayourian, Joshua, Dave, Jaydev, Hulot, Jean-Sébastien, Hajjar, Roger J.
Publicado no J Clin Transl Sci (2018)

3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythm...

Por Stillitano, Francesca, Turnbull, Irene C., Dave, Jaydev, Hulot, Jean-Sébastien, Hajjar, Roger J.
Publicado no J Clin Transl Sci (2019)

Multi-ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes

Por Martis, Suparna, Peter, Inga, Hulot, Jean-Sébastien, Kornreich, Ruth, Desnick, Robert J., Scott, Stuart A.
Publicado em 2012

Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension

Por Fouassier, David, Blanchard, Anne, Fayol, Antoine, Bobrie, Guillaume, Boutouyrie, Pierre, Azizi, Michel, Hulot, Jean‐Sébastien
Publicado no ESC Heart Fail (2020)

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes

Por Hulot, Jean-Sébastien, Stillitano, Francesca, Salem, Joe Elie, Kovacic, Jason C, Fuster, Valentin, Hajjar, Roger J
Publicado em 2014

Cyclic Nucleotide Compartmentalization: Contributions of Phosphodiesterases and ATP-Binding Cassette Transporters

Por Cheepala, Satish, Hulot, Jean-Sebastien, Morgan, Jessica A., Sassi, Yassine, Zhang, Weiqiang, Naren, Anjaparavanda P., Schuetz, John D.
Publicado no Annu Rev Pharmacol Toxicol (2012)

Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis

Por Sanchez-Pena, Paola, Hulot, Jean-Sébastien, Urien, Saïk, Ankri, Annick, Collet, Jean-Philippe, Choussat, Rémi, Lechat, Philippe, Montalescot, Gilles
Publicado em 2005

Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

Por Costedoat‐Chalumeau, Nathalie, Amoura, Zahir, Hulot, Jean‐Sébastien, Aymard, Guy, Leroux, Gaëlle, Marra, Donata, Lechat, Philippe, Piette, Jean‐Charles
Publicado em 2007

Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases

Por Leroux, Gaëlle, Costedoat‐Chalumeau, Nathalie, Hulot, Jean‐Sébastien, Amoura, Zahir, Francès, Camille, Aymard, Guy, Lechat, Philippe, Piette, Jean‐Charles
Publicado em 2007

Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice

Por Hara, Yannis, Sassi, Yassine, Guibert, Christelle, Gambaryan, Natacha, Dorfmüller, Peter, Eddahibi, Saadia, Lompré, Anne-Marie, Humbert, Marc, Hulot, Jean-Sébastien
Publicado em 2011

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19

Por Scott, Stuart A., Sangkuhl, Katrin, Shuldiner, Alan R., Hulot, Jean-Sébastien, Thorn, Caroline F., Altman, Russ B., Klein, Teri E.
Publicado em 2012

Influence of Genetic Variations on Levels of Inflammatory Markers of Healthy Subjects at Baseline and One Week after Clopidogrel Therapy; Results of a Preliminary Study

Por Shahabi, Payman, Siest, Gérard, Herbeth, Bernard, Lambert, Daniel, Masson, Christine, Hulot, Jean-Sébastien, Bertil, Sébastien, Gaussem, Pascale, Visvikis-Siest, Sophie
Publicado em 2013